期刊档案 · 医学-医学:内科

Journal of Korean Medical Science

ISSN 1011-8934 · eISSN 1598-6357 · Korean Academy of Medical Science · SOUTH KOREA · Bimonthly · 创刊 1986

Journal of Korean Medical Science 中科院 医学 4区(2025 年升级版),影响因子 3.09,完全开放获取,收取 APC,金额未公布,近 24 个月 92 篇文章投稿到接收中位 104 天,录用比例容易(社区反馈),2025 年发文 316 篇,SCIE、Scopus 收录。

影响因子3.09LetPub 汇总的最新公布值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 3区
审稿周期104 天投稿到接收中位数 · 近 24 个月 92 篇文章 · Crossref
版面费收取 APC,金额未公布完全开放获取
录用比例容易投稿社区平均反馈
年发文量316 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Journal of Korean Medical Science 由 Korean Academy of Medical Science 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 SARS-CoV-2 and COVID-19 Research、COVID-19 Clinical Research Studies、Liver Disease Diagnosis and Treatment 等主题的论文,这 3 个主题约占 19.8%。(根据 OpenAlex 主题统计与中科院分区数据生成)

The Journal of Korean Medical Science (JKMS) is an international, Open Access, peer-reviewed weekly journal of medicine published online only in English. The Journal's publisher is the Korean Academy of Medical Sciences (KAMS). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.

摘自期刊官网 Aims & Scope

研究方向(LetPub):医学-医学:内科

主编 Jin-Hong Yoo出版商官网

编委会国家分布:未见中国大陆编委;主要国家 韩国 17、中国香港 4、美国 1、英国 1、日本 1(共 25 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. SARS-CoV-2 and COVID-19 ResearchMedicine7%
  2. COVID-19 Clinical Research StudiesMedicine6.8%
  3. Liver Disease Diagnosis and TreatmentMedicine6%
  4. Academic Publishing and Open AccessDecision Sciences5.2%
  5. Neonatal Respiratory Health ResearchMedicine5.1%
  6. Health and Wellbeing ResearchHealth Professions5%
  7. Asthma and respiratory diseasesMedicine4.7%
  8. COVID-19 and Mental HealthPsychology4%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类医学:内科MEDICINE, GENERAL & INTERNAL3 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 3 区
类别学科分区
大类医学3 区
小类医学:内科MEDICINE, GENERAL & INTERNAL3 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 3 区
类别学科分区
大类医学3 区
小类医学:内科MEDICINE, GENERAL & INTERNAL3 区

Top 期刊:否综述期刊:否

数据库收录

SCIEScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

Web of ScienceMEDLINEPMC出版商官网

其他:Google Scholar、Crossref、KoreaMed

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
3.09LetPub ·
CiteScore 2026-06
5LetPub ·
SJR 2026-06
0.9LetPub ·
SNIP 2026-06
1.1LetPub ·
h-index
56LetPub ·
h-index
112OpenAlex ·
i10-index
4,851OpenAlex ·
两年平均被引
2.98OpenAlex ·
自引率
6.2%LetPub ·
Gold OA 文章占比
97.98%LetPub ·

发文规模

年文章数
284LetPub ·

逐年发文量 OpenAlex 统计 · 累计 8,792 篇 · 当年数据不完整

年份发文量其中 OA被引
202631931961
2025316316792
20243723722,151
20234274273,749
20223633634,476
20213453456,400

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 Crossref 登记的稿件日期 · 至

104 天投稿到接收中位数 · P25–P75 61 天 – 147 天

接收到上线
中位数 127 天(93 篇)
投稿到上线
中位数 222 天
样本
92 篇有投稿与接收日期的文章(窗口内共 688 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
一般,3-6周LetPub ·
平均录用比例(社区反馈)
容易LetPub ·
录用率(出版商公布)
8.9%出版商官网 ·
投稿到发表(期刊自报)
约 12 周DOAJ ·
评审方式
同行评审(未说明方式)DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJKRW 900,000有CC BY-NC
OpenAlexKRW 900,000——
LetPubKRW 900,000有—
出版商官网有,金额未公布——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

接收的文章类型10 种
  1. brief communicationsBrief communications are short original research articles on issues important to medical researchers.未说明篇幅
  2. case conference for cme in jkmsCase conference for CME in JKMS are descriptive materials for discovering typical cases of major diseases that are currently observed in Korea with high educati…未说明篇幅
  3. case reportsCase reports deal with clinical cases of medical interest or innovation.未说明篇幅
  4. correspondencesCorrespondences include reader comments on articles published in JKMS and replies from the authors.未说明篇幅
  5. editorialsEditorials are invited perspectives on an area of medical science, dealing with very active fields of research, current medical interests, fresh insights and de…未说明篇幅
  6. guidelinesGuidelines are instructions for practical medical care or technical details of writing and drawing.未说明篇幅
  7. invited review articlesReview articles provide a concise review of a subject of importance to medical researchers written by an invited expert in medical science.未说明篇幅
  8. opinionsOpinions suggest creative perspectives for medical issues.未说明篇幅
  9. original articlesOriginal articles are papers reporting the results of basic and clinical investigations that are sufficiently well documented to be acceptable to critical reade…未说明篇幅
  10. special articlesSpecial articles are invited with an intention of special introduction of medical information.未说明篇幅
出版商官网
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、许可与版权、同行评审、查重、预印本
作者资格 Authorship

The JKMS follows the recommendations for authorship by the ICMJE, 2025 (http://www.icmje.org/icmje-recommendations.pdf) and Good Publication Practice Guidelines for Medical Journals 3rd Edition (KAMJE, 2019, https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=). Authorship credit should be based on 1) Substantial contributions to the conception or design of the work; or the …

原文 ↗出版商官网 ·
利益冲突 XI. DISCLOSURE OF ARTIFICIAL INTELLIGENCE (AI)-ASSISTED TECHNOLOGY

If artificial intelligence (AI)-assisted technologies (such as large language models, chatbots, or image creators) were used during preparation of the manuscript, authors should disclose how they used AI in both the cover letter and the submitted work. Authors are responsible for scientific integrity of all contents that AI generated. Authors should not list AI-assisted technologies as an author o…

原文 ↗出版商官网 ·
数据可用性 Data sharing statement

JKMS accepts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results should submit a data sharing statement following the ICMJE guidelines from 1 July 2018. Authors may refer to the editorial, “Data Sharing statements for Clinical Trials: A Requirement of the International Committee of Medical Journa…

原文 ↗出版商官网 ·
出版伦理 VI. ETHICAL CONSIDERATIONS

Research Ethics All manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), World Association of Medical Editors (WAME, http://www.wame.org/), and the Korean Association of Medical …

原文 ↗出版商官网 ·
许可与版权 XIII. COPYRIGHT

Copyright policy 模型摘要

All authors of accepted manuscripts must sign a copy of the Journal's “Authorship Responsibility and License Agreement” form and submit it to Fax: +82.2-794-3148 or E-mail: jkms@kams.or.kr. For the copyrights of the contributions published in JKMS see Creative Commons (Attribution-Noncommercial) at http://creativecommons.org.

原文 ↗出版商官网 ·
同行评审 IV. EDITORIAL AND PEER REVIEW PROCESS

Anonymity of referees 模型摘要

JKMS reviews all manuscripts received. A manuscript is previewed for its format and academic relevancy, and then rejected or sent to the 3 most relevant investigators available for review of the contents. The editor selects peer referees by recommendation of the Editorial Board members or from the Board's specialist database. In addition, if deemed necessary, a review of statistics may be requeste…

原文 ↗出版商官网 ·
查重 Redundant Publication and Plagiarism

Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)”. Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant pu…

原文 ↗出版商官网 ·
预印本

Preprint policy 模型摘要

Preprinted manuscripts in medRxiv, bioRxiv or similar platforms are allowed to be submitted to the Journal.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Korean Academy of Medical Science
出版国家或地区
SOUTH KOREA
出版语言
English
出版周期
Bimonthly
创刊年份
1986
ISSN
1011-8934
电子版 ISSN
1598-6357
官网最新一期
Volume 41, Issue 36(2026 年 9 月)
官方链接

常见问题

关于 Journal of Korean Medical Science 的常见问题

Journal of Korean Medical Science 是中科院几区期刊?

2025 年升级版分区表中,Journal of Korean Medical Science 为医学 4区,小类 医学:内科 3 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。

Journal of Korean Medical Science 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 3.09,CiteScore 为 5,h-index 为 112。

Journal of Korean Medical Science 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)92 篇已发表文章登记的日期,投稿到接收的中位数为 104 天(四分位 61–147 天);投稿社区反馈的平均审稿速度为3–6 周,平均录用比例反馈为“容易”;期刊官网公布的录用率为 8.9%。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Journal of Korean Medical Science 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 25 位编委中,没有中国大陆学者;人数最多的国家是 韩国(17 位)、中国香港(4 位)、美国(1 位)。统计按编委会页面列出的机构国家计,仅供参考。

Journal of Korean Medical Science 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Journal of Korean Medical Science 被 SCIE、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、MEDLINE、PMC 收录,该清单未与各数据库逐一核对。

Journal of Korean Medical Science 是开放获取期刊吗?版面费多少?

Journal of Korean Medical Science 为完全开放获取。收取 APC,金额未公布。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。